Questo Corso è inserito nel programma ECM del Ministero della Salute come attività formativa n° 157-446292 per n°130 partecipanti tra Medici Chirurghi Specialisti in Allergologia e Immunologia Clinica, Malattie dell’Apparato Respiratorio, Medicina Interna, Reumatologia, Ortopedia e Traumatologia. Il Convegno ha ottenuto n°5,6 Crediti Formativi.

Il Corso si terrà i giorni 21-22-23 Maggio 2024 presso lo StarHotels Business Palace, Milano.

L’assegnazione dei crediti è subordinata alla partecipazione effettiva dell’intero programma formativo, alla verifica dell’apprendimento via app o sito web ed al rilevamento delle presenze tramite sistema a badge elettronici. Ai fini dell’acquisizione dei crediti formativi ECM, è necessario compilare la scheda di registrazione online in tutte le sue parti inserendo chiaramente nome, cognome, codice fiscale, indirizzo e disciplina. La frequenza sarà verificata in entrata ed uscita per tutta la durata dei Corsi. Al termine dei lavori è previsto, per coloro che ne fanno richiesta, un attestato di partecipazione.

Responsabile Scientifico: Roberto Caporali

Istruzioni per l’iscrizione

Rationale

The landscape of rheumatology is undergoing a profound transformation with the emergence of precision medicine and personalized medicine approaches. While these terms are often used interchangeably, they represent distinct paradigms that offer unique opportunities and challenges in managing rheumatic diseases. This congress aims to explore and clarify these approaches while addressing their practical implementation in rheumatology care.

Rheumatic diseases represent a complex spectrum of disorders characterized by their heterogeneous nature, variable progression patterns, and diverse treatment responses. Traditional “one-size-fits-all” treatment approaches have shown limited success in managing these conditions effectively, leading to the emergence of more targeted strategies.

The field faces several critical challenges as high variability in disease manifestations and progression, unpredictable treatment responses, complex interactions between genetic, environmental, and lifestyle factors, limited understanding of disease subtypes and endotypes, growing array of therapeutic options with varying effectiveness across patient subgroups

Precision Medicine vs Personalized Medicine?

This congress will explore the fundamental differences between these approaches:

Precision Medicine is focused on:

• stratifying patients into subgroups based on biomarkers, genetics, and molecular pathways
• use of advanced technologies and “-omics” approaches
• identification of specific disease mechanisms and targeted treatments

Personalized Medicine is based on:

• the individual patient’s broader context, including lifestyle, preferences, and social factors
• incorporation of patient-reported outcomes and quality of life measures
• sharing decision-making and patient engagement

During the congress wili be discussed

1. Diagnostic approaches as novel biomarker discovery, integration of multi-omics data, artificial intelligence
2. Treatment Strategies as biomarker-guided therapy selection, prediction models for treatment response, patient-specific dosing approaches, risk stratification methods, decision support tools, integration of real-world evidence

Through interactive sessions, expert presentations, and collaborative discussions, this congress will address the crucial question of how to effectively combine precision and personalized medicine approaches to optimize the management of rheumatic diseases while maintaining practical feasibility in real-world clinical settings.